After receiving the Day 74 letter, which outlines the FDA’s initial assessment of the application, the agency accepted Epioxa ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

The Advisory Committee on Immunization Practices (ACIP) that makes recommendations to the Centers for Disease Control and ...

So far, five biosimilars that reference Eylea 2 mg have been approved by the FDA. Alvotech/Teva expect to regulatory approval ...

Merilog is expected to be available in July 2025, and Sanofi will provide Merilog to patients for $35 or less for a 30-day ...

An expert discusses the key side effects and contraindications associated with antifibrotic agents and how to monitor for and ...

Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

A large study analyzed suicide deaths among veterans with newly diagnosed post-traumatic stress disorder (PTSD) who did or ...

Funding will be cut to $10 million, which is a nearly 90% decrease from 2024’s budget of $98 million.

An expert discusses the management plan for patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary ...

Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...